气道炎症加快了囊性纤维化肺部恶化
Theodore G Liou1,2, Natalia Argel3, Fadi Asfour2
1Adult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USA.
iScience
|February 22, 2024
概括
这项研究确定了10种炎症生物标志物,预测了青少年和成人未来的囊性纤维化 (CF) 肺部恶化. 针对RAGE轴炎症,蛋白酶损伤和氧化应激的治疗可以预防这些事件.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 气道炎症是囊性纤维化 (CF) 肺部恶化的主要驱动因素.
- 预测和预防这些恶化仍然是一个临床挑战.
研究的目的:
- 确定与炎症相关的生物标志物,预测CF患者未来的肺部恶化.
- 探索临床因素和治疗对这些生物标志物协会的影响.
主要方法:
- 在114名患有CF的临床稳定青少年和成年人中进行了前性多中心研究.
- 使用比例危险模型对24种与炎症相关的分子进行分析.
- 评估与未来恶化的关系,由肺功能介导 (预测FEV1的百分比).
主要成果:
- 十个生物标志物与未来的CF肺部恶化有显著的关联,由FEV1.1调解.
- 这些关联独立于抗炎药物,抗生素和CFTR调节器疗法.
- 这些发现代表了研究期间的美国CF人口.
结论:
- 特定的炎症生物标志物可以预测CF中的肺部恶化.
- 针对RAGE轴炎症,蛋白酶介导损伤和氧化应激的组合疗法可能提供一种新的预防策略.
- 这些发现也可能为其他呼吸道炎症疾病,如支气管炎症和ARDS的管理提供信息.
相关概念视频
Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164
Cystic Fibrosis: Pathogenesis
241
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
241
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


